Changes of breath volatile organic compounds in healthy volunteers following segmental and inhalation endotoxin challenge.


Journal

Journal of breath research
ISSN: 1752-7163
Titre abrégé: J Breath Res
Pays: England
ID NLM: 101463871

Informations de publication

Date de publication:
03 05 2022
Historique:
received: 26 10 2021
accepted: 01 04 2022
pubmed: 3 4 2022
medline: 30 4 2022
entrez: 2 4 2022
Statut: epublish

Résumé

It is still unclear how airway inflammation affects the breath volatile organic compounds (VOCs) profile in exhaled air. We therefore analyzed breath following well-defined pulmonary endotoxin (lipopolysaccharide, LPS) challenges. Breath was collected from ten healthy non-smoking subjects at eight time points before and after segmental and whole lung LPS inhalation challenge. Four Tenax-TA® adsorption tubes were simultaneously loaded from an aluminum reservoir cylinder and independently analyzed by two research groups using gas chromatography-mass spectrometry. Airway inflammation was assessed in bronchoalveolar lavage (BAL) and in sputum after segmental and inhaled LPS challenge, respectively. Segmental LPS challenge significantly increased the median (interquartile range, IQR) percentage of neutrophils in BAL from 3.0 (4.2) % to 64.0 (7.3) %. The inhalation challenge increased sputum neutrophils from 33.9 (26.8) % to 78.3 (13.5) %. We observed increases in breath aldehydes at both time points after segmental and inhaled LPS challenge. These results were confirmed by an independent laboratory. The longitudinal breath analysis also revealed distinct VOC patterns related to environmental exposures, clinical procedures, and to metabolic changes after food intake. Changes in breath aldehydes suggest a relationship to LPS induced inflammation compatible with lipid peroxidation processes within the lung. Findings from our longitudinal data highlight the need for future studies to better consider the potential impact of the multiple VOCs from detergents, hygiene or lifestyle products a subject is continuously exposed to. We suspect that this very individual 'owncloud' exposure is contributing to an increased variability of breath aldehydes, which might limit a use as inflammatory markers in daily clinical practice.

Identifiants

pubmed: 35366648
doi: 10.1088/1752-7163/ac6359
doi:

Substances chimiques

Aldehydes 0
Endotoxins 0
Lipopolysaccharides 0
Volatile Organic Compounds 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Creative Commons Attribution license.

Auteurs

Olaf Holz (O)

Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Clinical Airway Research, Hannover 30625, Germany.
Member of the German Center for Lung Research (BREATH), Hannover, Germany.

Robert van Vorstenbosch (R)

Department of Pharmacology and Toxicology, NUTRIM School of Nutrition and Translational Research, Maastricht University, Maastricht, The Netherlands.

Frank Guenther (F)

Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Bio- and Environmental Analytics, Hannover, DE 30625, Germany.

Sven Schuchardt (S)

Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Bio- and Environmental Analytics, Hannover, DE 30625, Germany.

Frederik Trinkmann (F)

Pneumology and Critical Care Medicine, Thoraxklinik at University Hospital Heidelberg, Translational Lung Research Center Heidelberg (TLRC), Heidelberg 69126, Germany.

Frederik-Jan van Schooten (FJ)

Department of Pharmacology and Toxicology, NUTRIM School of Nutrition and Translational Research, Maastricht University, Maastricht, The Netherlands.

Agnieszka Smolinska (A)

Department of Pharmacology and Toxicology, NUTRIM School of Nutrition and Translational Research, Maastricht University, Maastricht, The Netherlands.

Jens M Hohlfeld (JM)

Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Clinical Airway Research, Hannover 30625, Germany.
Member of the German Center for Lung Research (BREATH), Hannover, Germany.
Department of Respiratory Medicine, Hannover Medical School (MHH), Hannover, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH